Trials / Completed
CompletedNCT05765487
Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%
Phase 1 Single-Dose Double-Blind Vehicle-Controlled 3-Way Crossover Study Using Thermography to Assess the Pharmacodynamics and Pharmacokinetics of L-Arginine and Sildenafil Contained in Sildenafil Cream 3.6% in Normal Healthy Premenopausal Women
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Daré Bioscience, Inc. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to compare thermography images in normal healthy premenopausal women after the application of Sildenafil Cream, 3.6%, L-arginine cream, and placebo cream. Participants will be shown a series of explicit videos to elicit a change in genital temperature before and after application of cream.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil | Sildenafil Cream, 3.6% |
| DRUG | Vehicle | No Active or experimental ingredients |
| DRUG | Placebo | Cream with only L-arginine |
Timeline
- Start date
- 2023-05-13
- Primary completion
- 2024-01-26
- Completion
- 2024-10-21
- First posted
- 2023-03-13
- Last updated
- 2025-09-04
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05765487. Inclusion in this directory is not an endorsement.